Trellis Bioscience
PrivateLast Round
Series C
Jul 16, 2026
Total Funding Raised
$26.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Trellis Bioscience is a biotechnology company that develops native human monoclonal antibody therapies for infectious diseases and cancer using its proprietary CellSpot™ discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trellis Bioscience Comparables
Compare Trellis Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Peptilogics | 80% | |
| Aridis Pharmaceuticals, Inc. | 79% | |
| Clarametyx Biosciences | 77% | |
Trellis Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 16, 2026 | ||||
| Series C | May 15, 2026 | ||||
| VC Round | Oct 22, 2024 | ||||
| Grant | Jul 18, 2024 | ||||
| Grant | Jan 14, 2020 | ||||
Grant | Aug 16, 2012 |
Key People
Founding team and executive leadership
Trellis Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pac-Link Bio Venture Investment Corporation | Series B |
| AMR Action Fund | Series C |
| National Institute of Allergy and Infectious Diseases | Grant |
| CARB-X | Grant |
| Sagamore Bioventures LLC | Series B |
| Easton-Hunt Capital Partners, L.P. | Series B, Series C |
| Nodenza Venture Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
$9M round led by Easton-Hunt Capital Partners.
- May 15, 2026
$6.1M raised in Seed Round.
Trellis Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trellis Bioscience's valuation, stock price, and market status.